Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Efficacy of Oxybates for REM Behavior Disorder in Narcolepsy Patients

Mechanism and Evidence for RBD Improvement

  • The American Academy of Sleep Medicine strongly recommends sodium oxybate for the treatment of narcolepsy in adults due to clinically significant improvements in multiple narcolepsy symptoms, including cataplexy, excessive daytime sleepiness, and disrupted nocturnal sleep 3, 4
  • Sodium oxybate is effective in treating other symptoms of narcolepsy, in addition to improving RBD symptoms, with significant improvement in the REM sleep atonia index and remarkable reduction in complex movements during REM sleep in patients with narcolepsy 1, 2

Dosing and Administration

  • Sodium oxybate is administered as a liquid in two divided doses at night, with the first dose at bedtime and the second dose 2.5-4 hours later, as recommended by the American Academy of Sleep Medicine 2
  • The American Academy of Sleep Medicine conditionally recommends sodium oxybate for narcolepsy treatment in pediatric patients 5, 6

Safety Considerations

  • Sodium oxybate carries an FDA black box warning as it is a central nervous system depressant that may cause respiratory depression, and is an FDA Schedule III controlled substance (sodium salt of gamma hydroxybutyrate/GHB) 3, 5
  • Common adverse events associated with sodium oxybate include weight loss, enuresis, nausea, vomiting, headache, decreased appetite, nasopharyngitis, and dizziness, as reported by the American Academy of Sleep Medicine 5, 6

Special Populations and Monitoring

  • For elderly patients, careful monitoring is required due to potential adverse effects, as recommended by the American Geriatrics Society 1, 7
  • The medication should be used with caution in patients with respiratory conditions due to potential respiratory depression, and in patients with a history of substance abuse due to its potential for misuse, as advised by the American Academy of Sleep Medicine 3, 5

Monitoring Recommendations

  • Regular follow-up is necessary to assess treatment efficacy and adverse effects, including evaluation for adverse effects, particularly respiratory depression, as recommended by the American Academy of Sleep Medicine 2, 5, 8

REFERENCES

1

treatment of central disorders of hypersomnolence: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021

2

treatment of central disorders of hypersomnolence: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021

5

treatment of central disorders of hypersomnolence: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021

6

treatment of central disorders of hypersomnolence: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021